首页    期刊浏览 2024年11月24日 星期日
登录注册

文章基本信息

  • 标题:Economic Evaluation of Different Organizational Models for the Management of Patients with Hepatitis C
  • 本地全文:下载
  • 作者:Stefano Fagiuoli ; Luisa Pasulo ; Franco Maggiolo
  • 期刊名称:Farmeconomia. Health economics and therapeutic pathways
  • 印刷版ISSN:2240-256X
  • 出版年度:2019
  • 卷号:20
  • 期号:1
  • 页码:1-11
  • DOI:10.7175/fe.v20i1.1374
  • 出版社:SEEd
  • 摘要:BACKGROUND: Access to Directly Acting Antivirals (DAAs) for Hepatitis C Virus (HCV) treatment in Italy was initially restricted to severe patients. In 2017, AIFA expanded access to all patients, to achieve elimination by 2030. AIM: To investigate the impact of different hospitals’ organizational models on elimination timing, treatment capacity and direct costs. METHODS: Most Regional healthcare systems in Italy deploy a Center of Excellence (CoE) organizational model, where patients are referred to a single major hospital in the area, which is the only one that can prescribe and deliver DAAs. The study was conducted at Bergamo’s (Lombardy, Italy) Papa Giovanni XXIII hospital (PG-23), which deploys a Hub&Spoke model: the Hub (PG-23) prescribes and delivers DAAs while Spokes (four smaller hospitals) can only prescribe them. The study compares the two models (CoE vs. H&S). Patient journey and workloads were mapped and quantified through interviews with hospital stakeholders. Cost data were collected through the hospital’s IT system; the sample comprised 2,277 HCV patients, over one year. RESULTS: The study calculated the average cost to treat HCV patients (~ € 1,470 per patient). Key cost drivers are lab tests (60%) and specialist visits (30%). Over one year, H&S can treat 68% more patients than CoE. As deferred patients absorb up to 40% of total costs, the “Optimized” model was designed by streamlining specialists’ visits and involving general practitioners during follow-up. “Optimized” model increases treatment capacity and reduces costs of deferred patients by 72% vs CoE. CONCLUSION: The study demonstrates the importance of organizational models in efficiently achieving 2030 elimination.
  • 关键词:Hepatitis C; Italy; Models; Organizational; Antiviral Agents; DAA; HCV; Hub & Spoke; Center of Excellence
  • 其他关键词:Hepatitis C;Italy;Models; Organizational;Antiviral Agents;DAA;HCV;Hub & Spoke;Center of Excellence
国家哲学社会科学文献中心版权所有